Navigation Links
Covance Reports Fourth Quarter and Full-Year 2008 Results
Date:1/28/2009

PRINCETON, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today reported earnings for its fourth quarter ended December 31, 2008 of $0.72 per diluted share. For the full-year, earnings per share were $3.08, up 13.3% year-on-year from $2.71 in 2007. Excluding the gain on sale of Covance's centralized ECG business from both years, earnings per share grew 14.5% to $3.03 in 2008 from $2.65 in 2007.

"As previously announced, reduced demand in our Early Development segment from a combination of a lower level of new project initiations and increased project delays in our toxicology and clinical pharmacology services led to a sequential decline in segment revenue and operating income," said Joe Herring, Chairman and Chief Executive Officer. "Demand for our Late-Stage Development services remained on-track in the fourth quarter, including revenue growth of 10.5% (13.5% excluding the impact of foreign exchange), operating margins of 19.6%, record orders, and a net book-to-bill exceeding 1.6 to 1. On a consolidated basis, fourth quarter net revenues grew 6.7% (10.9% excluding the impact of foreign exchange), operating margin was 14.5%, and EPS was flat year-on-year (excluding the gain on sale from both periods).

"On the commercial front, adjusted net orders in the fourth quarter were $567 million ($555 million on an unadjusted basis), representing an adjusted book-to-bill ratio of 1.29 to 1. Backlog grew 62% year-on-year to $4.33 billion. In addition, in the latter part of 2008, we secured two seven-year, sole source contracts for our central laboratory services from top-ten drug companies, under which orders will be recognized as new projects are awarded.

"On December 18 we released our targets for 2009, which outlined revenue growth of 5% to 10% over 2008 and earnings per share in the range of $3.00
'/>"/>

SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Covance to Present at the UBS Global Life Sciences Conference
2. Covance Elects Dr. Gary E. Costley to Board of Directors
3. Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRTs Centralized Cardiac Safety Services
4. eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance
5. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
6. Covance and Care Partner on Rwanda Early Childhood Development Initiative
7. Wendel Barr Appointed Chief Operating Officer of Covance
8. Covance to Present at 26th Annual JPMorgan Healthcare Conference
9. Covance to Present at UBS Global Healthcare Services Conference
10. Covance to Present at Raymond James 29th Annual Institutional Investors Conference
11. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Ras Al Khaimah, UAE (PRWEB) May 05, 2015 ... Grace Century , FZ LLC has announced that ... ’, monthly enrollment for Store-A-Tooth™ increased once again--in April, ... the company’s 40th month of increased record volume and ... , Marketing for Provia’s dental stem cell biobank is ...
(Date:5/5/2015)... Beverly Hills Cosmetic Dentist, Arthur Glosman released a ... be sold at the offices of Arthur Glosman DDS, 450 ... through an online store . “I wanted to be ... dental care and beauty with a luxurious collection of products ... Glosman. , Dr. Glosman’s Advanced Dental Health + Beauty™ ...
(Date:5/5/2015)... Scottsdale, AZ (PRWEB) May 05, 2015 ... NCPDP’s Elite Partner Program. The program establishes a three-year ... to a maximum of 10 Elite Partners. “AmerisourceBergen has ... Ann Stember, President of NCPDP, “and this is a ... work. , We can trace AmerisourceBergen back to ...
(Date:5/5/2015)... AxoGen, Inc. (NASDAQ: AXGN), a ... peripheral nerve repair market, reported record revenue of $4.95 ... compared to $3.14 million in the year-ago first quarter. ... portfolio of nerve repair products - Avance® Nerve ... and our solid sales execution delivered another record quarter ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 ... Health IVF Clinic in Greece, an experienced team ... and treatment of infertility for patients around the globe. ... partnered with VisitandCare.com. Greece unquestionably remains a global leader ... most talented and hard-working fertility specialists in the world ...
Breaking Medicine News(10 mins):Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3
... float the first 'global health bonds' to raise $ 4 ... poor, and strengthen global immunization efforts.// ,The move will ... world to become part of the efforts to make healthcare ... investment. ,Giving information about the bonds that are ...
... of Washington University writes in his latest book Doctor’s ... has been a great scientist, inventor, publisher and statesman.// ... education has contributed a lot to preventive and modern ... America during the 18th Century in a period where ...
... Improvement has funded a grant of $30,000 to Medical ... Care to understand the usefulness of online information systemhas ... online information system woulc be helpulf for managing multiple ... to apply and the 20 selected for support from ...
... by Brian Carpenter, Ph.D., of the Washington University in St. ... two adult siblings with regard to their parents’ wants. // ... across. There is nothing which clearly indicates as to which ... wants. ,The children who feel that they ...
... the brain spring into action when one if faced with ... Hsu of the California Institute of Technology in Pasadena and ... betting games. As they played, the scientists watched changes in ... one game, researchers gave them the chance to guess the ...
... basic vaccines and introduce three new ones.,"We will give India ... will provide $40 million and then more than double it ... ,Addressing a press conference after the conclusion of the ... made a lot of progress in the vaccination and immunization ...
Cached Medicine News:Health News:Health bonds to immunize the poor 2Health News:Online information system for patients 2Health News:Adult Children Fail to Understand Parents Wishes 2
(Date:5/6/2015)... 2015 AbbVie (NYSE: ABBV ) will ... Health Care Conference on Wednesday, May 13, 2015. ... will participate in a question and answer session at ... webcast of the presentation will be accessible through AbbVie,s ... archived edition of the session will be available later ...
(Date:5/6/2015)... May 6, 2015   Symbiomix Therapeutics today ... and final tranche of a $41 million Series A ... 2 trial testing a single oral dose of SYM-1219 ... discussions with the U.S. Food and Drug Administration (FDA) ... planning to submit the Phase 2 trial as one ...
(Date:5/6/2015)... STOCKHOLM , May 6, 2015   Wilson ... announced that CEO Jonas Hansson has been ... company during the annual BioEquity Conference, this year to ... CEST on May 19 th . ... tetrathiomolybdate, which is currently in Phase 2 testing for ...
Breaking Medicine Technology:Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 2Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 3Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 4Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 5Wilson Therapeutics To Present As A "Next Wave" Company During BioEquity 2015 Conference In Vienna On May 19th 2
... and AMSTERDAM, August 10, 2011 Agendia, ... the 12th St. Gallen International Breast Cancer Conference (2011) ... - classifying patients by the particular biological subtype of ... cancer patients. According to the panel, "it is no ...
... is unpredictable and can be even more so when you ... sneezing or itchy, watery eyes just might earn you top ... Facebook.  Allergy sufferers are invited to upload a short video ... win $5,000 toward a fun-filled adventure where they can enjoy ...
Cached Medicine Technology:International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 2International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 3Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 2Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 3Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 4
Arthroscopic instrument system for instability and SLAP fixation....
Suture Cutter, straight...
... Mini-Open Rotator Cuff Repair System facilitates ... time, incision size and the likelihood ... rotator cuff repair systems and implants. ... of matched cortical gauge punches, circular ...
Suture Cutters, Straight...
Medicine Products: